Literature DB >> 28097779

The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation.

Catherine Goudie1,2, Hallie Coltin1,3, Leora Witkowski4, Stephanie Mourad1, David Malkin2, William D Foulkes4,5,6.   

Abstract

Identifying cancer predisposition syndromes in children with tumors is crucial, yet few clinical guidelines exist to identify children at high risk of having germline mutations. The McGill Interactive Pediatric OncoGenetic Guidelines project aims to create a validated pediatric guideline in the form of a smartphone/tablet application using algorithms to process clinical data and help determine whether to refer a child for genetic assessment. This paper discusses the initial stages of the project, focusing on its overall structure, the methodology underpinning the algorithms, and the upcoming algorithm validation process.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer genetics; cancer predisposition syndrome; familial cancer; germline mutation; pediatric

Mesh:

Year:  2017        PMID: 28097779     DOI: 10.1002/pbc.26441

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass.

Authors:  David Malkin; Kim E Nichols; Joshua D Schiffman; Sharon E Plon; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-11-01       Impact factor: 12.531

3.  Clinical and molecular features of pediatric cancer patients with Lynch syndrome.

Authors:  Sarah Scollon; Mohammad K Eldomery; Jacquelyn Reuther; Frank Y Lin; Samara L Potter; Lauren Desrosiers; Kenneth L McClain; Valeria Smith; Jack Meng-Fen Su; Rajkumar Venkatramani; Jianhong Hu; Viktoriya Korchina; Neda Zarrin-Khameh; Richard A Gibbs; Donna M Muzny; Christine Eng; Angshumoy Roy; D Williams Parsons; Sharon E Plon
Journal:  Pediatr Blood Cancer       Date:  2022-06-30       Impact factor: 3.838

4.  Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.

Authors:  Catherine Goudie; Leora Witkowski; Noelle Cullinan; Lara Reichman; Ian Schiller; Melissa Tachdjian; Linlea Armstrong; Katherine A Blood; Josée Brossard; Ledia Brunga; Chantel Cacciotti; Kimberly Caswell; Sonia Cellot; Mary Egan Clark; Catherine Clinton; Hallie Coltin; Kathleen Felton; Conrad V Fernandez; Adam J Fleming; Noemi Fuentes-Bolanos; Paul Gibson; Ronald Grant; Rawan Hammad; Lynn W Harrison; Meredith S Irwin; Donna L Johnston; Sarah Kane; Lucie Lafay-Cousin; Irene Lara-Corrales; Valerie Larouche; Natalie Mathews; M Stephen Meyn; Orli Michaeli; Renée Perrier; Meghan Pike; Angela Punnett; Vijay Ramaswamy; Jemma Say; Gino Somers; Uri Tabori; My Linh Thibodeau; Annie-Kim Toupin; Katherine M Tucker; Kalene van Engelen; Stephanie Vairy; Nicolas Waespe; Meera Warby; Jonathan D Wasserman; James A Whitlock; Daniel Sinnett; Nada Jabado; Paul C Nathan; Adam Shlien; Junne Kamihara; Rebecca J Deyell; David S Ziegler; Kim E Nichols; Nandini Dendukuri; David Malkin; Anita Villani; William D Foulkes
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 33.006

Review 5.  Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies-A Review.

Authors:  Aleksandra Filipiuk; Agata Kozakiewicz; Kamil Kośmider; Monika Lejman; Joanna Zawitkowska
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

Review 6.  Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy.

Authors:  Linda Rossini; Caterina Durante; Silvia Bresolin; Enrico Opocher; Antonio Marzollo; Alessandra Biffi
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

7.  Using family history forms in pediatric oncology to identify patients for genetic assessment.

Authors:  A Hamilton; E Smith; J Hamon; E Tomiak; M Bassal; S L Sawyer
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

8.  Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.

Authors:  Scott Newman; Joy Nakitandwe; Chimene A Kesserwan; Elizabeth M Azzato; David A Wheeler; David W Ellison; James R Downing; Jinghui Zhang; Kim E Nichols; Michael Rusch; Sheila Shurtleff; Dale J Hedges; Kayla V Hamilton; Scott G Foy; Michael N Edmonson; Andrew Thrasher; Armita Bahrami; Brent A Orr; Jeffery M Klco; Jiali Gu; Lynn W Harrison; Lu Wang; Michael R Clay; Annastasia Ouma; Antonina Silkov; Yanling Liu; Zhaojie Zhang; Yu Liu; Samuel W Brady; Xin Zhou; Ti-Cheng Chang; Manjusha Pande; Eric Davis; Jared Becksfort; Aman Patel; Mark R Wilkinson; Delaram Rahbarinia; Manish Kubal; Jamie L Maciaszek; Victor Pastor; Jay Knight; Alexander M Gout; Jian Wang; Zhaohui Gu; Charles G Mullighan; Rose B McGee; Emily A Quinn; Regina Nuccio; Roya Mostafavi; Elsie L Gerhardt; Leslie M Taylor; Jessica M Valdez; Stacy J Hines-Dowell; Alberto S Pappo; Giles Robinson; Liza-Marie Johnson; Ching-Hon Pui
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 39.397

Review 9.  Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.

Authors:  Orli Michaeli; Uri Tabori
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01

10.  Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study.

Authors:  Raoul C Hennekam; Johannes H M Merks; Floor A M Postema; Saskia M J Hopman; Corianne A J M de Borgie; Cora M Aalfs; Jakob K Anninga; Lieke P V Berger; Fonnet E Bleeker; Charlotte J Dommering; Natasha K A van Eijkelenburg; Peter Hammond; Marry M van den Heuvel-Eibrink; Janna A Hol; Wijnanda A Kors; Tom G W Letteboer; Jan L C M Loeffen; Lisethe Meijer; Maran J W Olderode-Berends; Anja Wagner
Journal:  Fam Cancer       Date:  2021-03-09       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.